| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 160.35B | 154.81B | 143.45B | 142.82B | 124.78B | 109.05B |
| Gross Profit | 64.10B | 63.47B | 59.12B | 56.69B | 50.40B | 45.74B |
| EBITDA | 16.98B | 17.88B | 15.46B | 13.96B | 10.86B | 10.25B |
| Net Income | 6.66B | 7.15B | 3.56B | 4.18B | 3.79B | 12.96B |
Balance Sheet | ||||||
| Total Assets | 149.47B | 139.76B | 132.46B | 122.86B | 120.00B | 109.31B |
| Cash, Cash Equivalents and Short-Term Investments | 29.26B | 27.48B | 25.08B | 21.92B | 29.85B | 33.04B |
| Total Debt | 17.80B | 19.49B | 17.65B | 15.52B | 15.73B | 15.35B |
| Total Liabilities | 60.41B | 59.52B | 58.37B | 55.16B | 55.49B | 49.85B |
| Stockholders Equity | 84.71B | 76.55B | 71.30B | 65.48B | 63.16B | 58.30B |
Cash Flow | ||||||
| Free Cash Flow | 8.26B | 6.74B | 6.91B | -57.00M | -451.00M | 2.29B |
| Operating Cash Flow | 13.15B | 12.47B | 12.56B | 5.19B | 3.30B | 5.81B |
| Investing Cash Flow | -6.61B | -8.21B | -7.93B | 2.29B | -3.74B | -102.00M |
| Financing Cash Flow | -5.73B | -2.08B | -1.75B | -6.31B | -3.99B | -7.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥44.60B | 71.35 | ― | 4.43% | -2.18% | -24.34% | |
71 Outperform | ¥68.63B | 9.50 | 8.37% | 3.06% | 5.33% | 53.14% | |
70 Outperform | ¥44.35B | 14.45 | ― | 2.93% | 2.11% | -28.70% | |
70 Outperform | ¥292.28B | 6.34 | 12.24% | 2.31% | -3.29% | -30.26% | |
68 Neutral | ¥27.72B | 9.33 | 14.95% | 0.77% | 3.08% | -16.68% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
47 Neutral | ¥5.06B | 44.10 | ― | 2.01% | 14.05% | ― |